Only 18 percent of pharmaceutical drug ads are compliant with Food and Drug Administration regulations, a new study from the Mount Sinai School of Medicine found.
Dr. Deborah Korenstein, lead author of the study and Associate Professor of Medicine at Mount Sinai School of Medicine, said in a press release "Our study, the first in nearly 20 years to provide a systematic assessment of the adherence of U.S. advertisements to FDA guidance, shows that the current system is not in the best interest of the health of the public."
The study, which appeared online Wednesday in the journal Public Library of Science (PLoS) One, looked at 192 advertisements in nine biomedical journals appearing in November 2008. Researchers found only 57.8 percent of the ads quantified serious risks, including death. Only 48 percent had verifiable references and 29 percent could not accurately quantify effectiveness.
The study used the 20 prescription drug advertising guidelines provided by the FDA. About 49 percent of the ads didn't adhere to at least one of the guidelines, and 33 percent contained incomplete information.
http://www.thirdage.com/news/pharmaceutical-drug-ads-not-compliant-with-fda-regulations-study-finds_08-20-2011